Literature DB >> 17913823

Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells.

Maria Carlan Silva1, Antonieta Guerrero-Plata, Felicia D Gilfoy, Roberto P Garofalo, Peter W Mason.   

Abstract

Dendritic cells (DCs) play a central role in innate immunity and antiviral responses. In this study, we investigated the production of alpha interferon (IFN-alpha) and inducible chemokines by human monocyte-derived dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) infected with West Nile virus (WNV), an emergent pathogen whose infection can lead to severe cases of encephalitis in the elderly, children, and immunocompromised individuals. Our experiments demonstrated that WNV grown in mammalian cells (WNV(Vero)) was a potent inducer of IFN-alpha secretion in pDCs and, to a lesser degree, in mDCs. The ability of WNV(Vero) to induce IFN-alpha in pDCs did not require viral replication and was prevented by the treatment of cells with bafilomycin A1 and chloroquine, suggesting that it was dependent on endosomal Toll-like receptor recognition. On the other hand, IFN-alpha production in mDCs required viral replication and was associated with the nuclear translocation of IRF3 and viral antigen expression. Strikingly, pDCs failed to produce IFN-alpha when stimulated with WNV grown in mosquito cells (WNV(C7/10)), while mDCs responded similarly to WNV(Vero) or WNV(C7/10). Moreover, the IFN-dependent chemokine IP-10 was produced in substantial amounts by pDCs in response to WNV(Vero) but not WNV(C7/10), while interleukin-8 was produced in greater amounts by mDCs infected with WNV(C7/10) than in those infected with WNV(Vero). These findings suggest that cell-specific mechanisms of WNV recognition leading to the production of type I IFN and inflammatory chemokines by DCs may contribute to both the innate immune response and disease pathogenesis in human infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913823      PMCID: PMC2168853          DOI: 10.1128/JVI.00857-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Autophagy-dependent viral recognition by plasmacytoid dendritic cells.

Authors:  Heung Kyu Lee; Jennifer M Lund; Balaji Ramanathan; Noboru Mizushima; Akiko Iwasaki
Journal:  Science       Date:  2007-02-01       Impact factor: 47.728

2.  In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.

Authors:  S Löseke; E Grage-Griebenow; H Heine; A Wagner; S Akira; S Bauer; A Bufe
Journal:  Scand J Immunol       Date:  2006-04       Impact factor: 3.487

Review 3.  Natural type I interferon-producing cells as a link between innate and adaptive immunity.

Authors:  Norimitsu Kadowaki; Yong-Jun Liu
Journal:  Hum Immunol       Date:  2002-12       Impact factor: 2.850

4.  West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling.

Authors:  Brenda L Fredericksen; Michael Gale
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.

Authors:  Antonieta Guerrero-Plata; Antonella Casola; Giovanni Suarez; Xiang Yu; LeAnne Spetch; Mark E Peeples; Roberto P Garofalo
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-11       Impact factor: 6.914

6.  Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus.

Authors:  Veit Hornung; Jörg Schlender; Margit Guenthner-Biller; Simon Rothenfusser; Stefan Endres; Karl-Klaus Conzelmann; Gunther Hartmann
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

7.  CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis.

Authors:  K L Tyler; J Pape; R J Goody; M Corkill; B K Kleinschmidt-DeMasters
Journal:  Neurology       Date:  2005-12-28       Impact factor: 9.910

8.  Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus.

Authors:  Mario Lobigs; Arno Müllbacher; Yang Wang; Megan Pavy; Eva Lee
Journal:  J Gen Virol       Date:  2003-03       Impact factor: 3.891

9.  Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.

Authors:  Maria Rios; Ming J Zhang; Andriyan Grinev; Kumar Srinivasan; Sylvester Daniel; Owen Wood; Indira K Hewlett; Andrew I Dayton
Journal:  Transfusion       Date:  2006-04       Impact factor: 3.157

10.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

Authors:  Troy Querec; Soumaya Bennouna; Sefik Alkan; Yasmina Laouar; Keith Gorden; Richard Flavell; Shizuo Akira; Rafi Ahmed; Bali Pulendran
Journal:  J Exp Med       Date:  2006-02-06       Impact factor: 14.307

View more
  55 in total

Review 1.  Cell-intrinsic innate immune control of West Nile virus infection.

Authors:  Michael S Diamond; Michael Gale
Journal:  Trends Immunol       Date:  2012-06-20       Impact factor: 16.687

Review 2.  Innate host responses to West Nile virus: Implications for central nervous system immunopathology.

Authors:  Giada Rossini; Maria Paola Landini; Francesco Gelsomino; Vittorio Sambri; Stefania Varani
Journal:  World J Virol       Date:  2013-05-12

3.  Bovine viral diarrhea virus strain- and cell type-specific inhibition of type I interferon pathways.

Authors:  Amanda Gibson; Jenny Larsson; Michaela Bateman; Joe Brownlie; Dirk Werling
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 4.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

5.  In vitro analysis of MyD88-mediated cellular immune response to West Nile virus mutant strain infection.

Authors:  Guorui Xie; Melissa C Whiteman; Jason A Wicker; Alan D T Barrett; Tian Wang
Journal:  J Vis Exp       Date:  2014-11-27       Impact factor: 1.355

6.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Authors:  Jason R Wilson; Paola Florez de Sessions; Megan A Leon; Frank Scholle
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

9.  A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Toi Pham Van; Sue J Lee; Jeremy Farrar; Bridget Wills; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

10.  Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo.

Authors:  M Del Rocío Baños-Lara; Arpita Ghosh; Antonieta Guerrero-Plata
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.